Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures

    January 2019 in “ Frontiers in Immunology ”
    Andrés Pizzorno, Benjamin Terrier, Claire Nicolas de Lamballerie … Manuel Rosa‐Calatrava
    Studysummary This study identified diltiazem, a calcium channel blocker for hypertension, as a promising repurposed treatment for influenza, enhancing antiviral efficacy when combined with oseltamivir.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →